Back to Awarded Treatment Trials


Awarded Trial: 17T-005

Grant ID

17T-005

Illness

Bipolar depression

Primary Drug/Intervention

probiotic microorganisms (Lactobacillus GG, Bifidobacteria lactis strain Bb12)

Primary Dosage

10^8 colony forming units

Secondary Drug Intervention

N/A

Secondary Dosage

N/A

Other Drug/Intervention

N/A

Other Dosage

N/A

Status

Enrolling

Investigator

Sherwood Brown, M.D., Ph.D.

Sample Size

66

Duration of Study Period for Each Subject

24 weeks

Outcome Measurements

Primary outcome: Relapse, defined as rehspitalization (e.g., admission to an inpatient unit) for psychiatric symptoms following a previous hospital discharge by at least 2 weeks. Secondary outcomes: Occurrence of new mood episodes, severity of psychiatric symptoms, changes in cognitive test scores over the course of the study, changes in the levels of inflammatory markers, changes in gut microbiota.

Results

N/A

Publication

N/A

Link

N/A

PI Name

Sherwood Brown

Degree

M.D., Ph.D.

Center

University of Texas Southwestern Medical Center

Institution

N/A

Address

5323 Harry Hines Blvd, MC 8849

City or Town

Dallas

State or Province

TX

Zip or Postal Code

75390

Country

USA

Email Address

Sherwood.brown@utsouthwestern.edu